LVM Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.6M Sell
50,521
-173
-0.3% -$177K 5.07% 4
2026
Q1
$46.6M Sell
50,694
-503
-1% -$510K 4.4% 4
2025
Q4
$55M Sell
51,197
-343
-0.7% -$328K 5.11% 4
2025
Q3
$39.3M Buy
51,540
+784
+2% +$583K 3.78% 4
2025
Q2
$39.6M Buy
50,756
+1,186
+2% +$922K 4.1% 4
2025
Q1
$40.9M Buy
49,570
+1,008
+2% +$839K 4.56% 4
2024
Q4
$37.5M Buy
48,562
+11,534
+31% +$9.55M 4.03% 4
2024
Q3
$33.5M Hold
37,028
3.81% 4
2024
Q2
$33.5M Sell
37,028
-805
-2% -$644K 3.81% 4
2024
Q1
$29.4M Sell
37,833
-70
-0.2% -$49.8K 3.48% 5
2023
Q4
$22.1M Buy
37,903
+1,270
+3% +$741K 2.83% 8
2023
Q3
$19.7M Sell
36,633
-245
-0.7% -$126K 2.77% 9
2023
Q2
$17.3M Sell
36,878
-400
-1% -$168K 2.31% 12
2023
Q1
$12.8M Sell
37,278
-19
-0.1% -$6.41K 1.78% 17
2022
Q4
$13.6M Sell
37,297
-730
-2% -$259K 1.98% 15
2022
Q3
$12.3M Buy
38,027
+77
+0.2% +$24.4K 1.88% 18
2022
Q2
$12.3M Sell
37,950
-2,988
-7% -$897K 1.78% 21
2022
Q1
$11.7M Buy
40,938
+2,592
+7% +$667K 1.55% 25
2021
Q4
$10.6M Sell
38,346
-500
-1% -$127K 1.41% 25
2021
Q3
$8.97M Buy
38,846
+15
+0% +$3.7K 1.35% 27
2021
Q2
$8.91M Sell
38,831
-905
-2% -$182K 1.36% 28
2021
Q1
$7.42M Sell
39,736
-438
-1% -$85.7K 1.2% 29
2020
Q4
$6.78M Sell
40,174
-235
-0.6% -$35.1K 1.14% 32
2020
Q3
$5.98M Sell
40,409
-110
-0.3% -$17K 1.16% 30
2020
Q2
$6.65M Sell
40,519
-295
-0.7% -$45.3K 1.36% 28
2020
Q1
$5.66M Hold
40,814
1.4% 26
2019
Q4
$5.36M Buy
40,814
+175
+0.4% +$20.3K 1.06% 31
2019
Q3
$4.54M Sell
40,639
-100
-0.2% -$11.1K 0.97% 31
2019
Q2
$4.51M Sell
40,739
-600
-1% -$70.7K 1.03% 30
2019
Q1
$5.36M Hold
41,339
1.23% 29
2018
Q4
$4.78M Sell
41,339
-460
-1% -$51.4K 1.25% 27
2018
Q3
$4.49M Sell
41,799
-444
-1% -$44.4K 1.02% 30
2018
Q2
$3.6M Sell
42,243
-1,300
-3% -$107K 0.87% 34
2018
Q1
$3.37M Sell
43,543
-915
-2% -$73.7K 0.78% 35
2017
Q4
$3.75M Sell
44,458
-600
-1% -$51.1K 0.85% 35
2017
Q3
$3.85M Sell
45,058
-1,166
-3% -$95.6K 0.92% 32
2017
Q2
$3.8M Sell
46,224
-906
-2% -$73.9K 0.97% 31
2017
Q1
$3.96M Sell
47,130
-125
-0.3% -$10K 1.02% 31
2016
Q4
$3.48M Sell
47,255
-16,010
-25% -$1.19M 0.96% 31
2016
Q3
$3.93M Buy
63,265
+15,326
+32% +$1.23M 1.27% 27
2016
Q2
$3.77M Sell
47,939
-1,393
-3% -$105K 1.09% 29
2016
Q1
$3.55M Sell
49,332
-3,500
-7% -$265K 1.13% 26
2015
Q4
$4.45M Sell
52,832
-800
-1% -$66.4K 1.57% 25
2015
Q3
$4.49M Sell
53,632
-750
-1% -$63.3K 1.62% 27
2015
Q2
$4.54M Sell
54,382
-100
-0.2% -$7.62K 1.51% 26
2015
Q1
$3.96M Sell
54,482
-6,694
-11% -$477K 1.33% 29
2014
Q4
$4.22M Sell
61,176
-1,502
-2% -$101K 1.4% 26
2014
Q3
$4.07M Sell
62,678
-587
-0.9% -$37.2K 1.34% 27
2014
Q2
$3.93M Sell
63,265
-2,188
-3% -$131K 1.27% 27
2014
Q1
$3.85M Sell
65,453
-3,724
-5% -$208K 1.34% 26
2013
Q4
$3.53M Sell
69,177
-3,237
-4% -$162K 1.25% 28
2013
Q3
$3.65M Sell
72,414
-3,300
-4% -$173K 1.37% 29
2013
Q2
$3.72M Buy
+75,714
New +$4.12M 1.48% 28

Other funds holding LLY

LVM Capital Management's LLY Position: Q2 2026 in Review

LVM Capital Management reduced its Eli Lilly (LLY) stake by 0.34% in Q2 2026, selling an estimated $177K and leaving 50,521 shares worth $60.6M. The position accounts for 5.07% of the portfolio, ranked #4.

LVM Capital Management first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • LVM Capital Management held 50,521 shares of Eli Lilly worth $60.6M as of Q2 2026.
  • LVM Capital Management sold 173 Eli Lilly shares in Q2 2026, an estimated $177K.
  • Eli Lilly made up 5.07% of LVM Capital Management's portfolio in Q2 2026, its #4 holding.
  • LVM Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on LVM Capital Management's 13F filing for Q2 2026, filed 9 Jul 2026.